Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
SYNERGISTIC COMBINATIONS OF MONOCHLOROUREA AND MODIFIED MONOCHLOROUREAS
Document Type and Number:
WIPO Patent Application WO/2014/144272
Kind Code:
A1
Abstract:
The present invention provides synergistic combinations of monochlorourea with other biocides for controlling microbial growth in aqueous systems. It also provides synergistic combinations of dimethyl monochlorourea with other biocides for controlling growth in aqueous systems. The synergistic combinations of monochlorourea and dimethyl monochlorourea with other biocides allows for the reduced use of total biocides to provide control of microbial growth in aqueous systems.

Inventors:
CHAPMAN JOHN S (US)
Application Number:
PCT/US2014/028607
Publication Date:
September 18, 2014
Filing Date:
March 14, 2014
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
HERCULES INC (US)
International Classes:
A01P1/00; A01N47/28; A61K31/17; C07C273/18
Domestic Patent References:
WO2013140402A12013-09-26
WO2014020601A12014-02-06
Foreign References:
US20120121728A12012-05-17
US20100331416A12010-12-30
US20070178173A12007-08-02
Other References:
None
Attorney, Agent or Firm:
ROSSI, Joanne (500 Hercules RoadWilmington, DE, US)
Download PDF:
Claims:
CLAIMS

1. A microbicidal composition comprising:

a first biocide and at least one second biocide

wherein the first biocide is selected from the group consisting of monochlorourea and modified monochlorourea; and

wherein the second biocide is selected from the group consisting of methyl

monochlorourea, dimethyl monochlorourea, bromine activated monochloramine, monochloramine, hydrogen peroxide, 1-bromo-3-chloro-5,5-dimethylhydantoin, benzisothiazolone, 2-methylisothiazolone, tetrakis (hydroxym ethyl) phosphonium sulfate, methylene bisthiocyanate, 2-bromo-2-nitropropane-1,3,-diol, 2,2-dibromo-3- nitrilopropionamide, N-alkyl (Ci2-C1e)-N,N-dimethyl benzylalkonium chloride, the combination biocide 2-methyl-5-chloro-isothiazolin-3-one/2-methyl-isothazolin-3-one, and glutaraldehyde;

with the proviso that the first biocide is different from the second biocide.

2. The microbicidal composition of claim 1 wherein the first biocide is monochlorourea

3. The microbicidal composition of claim 1 wherein the first biocide is dimethyl monochlorourea.

4. The microbicidal composition of claim 1 wherein at least one first biocide is selected fron the group consisting of monochlorourea, N-methyl-monochlorourea, N'-methyl-N- monochlorourea, N,N-dimethyl-N'-monochlorourea, N,N'-dimethyl-N-monochlorourea, N- ethyl-N-monochlorourea, N'-ethyl-N-monochlorourea, N,N-diethyl-N'-monochlorourea, Ν,Ν'-diethyl-N-monochlorourea.

5. The microbicidal composition of any of claim 1 to 4 wherein the ratio of the first biocide to the second biocide is from 1 : 100 to 800: 1 or from 1 :50 to 400: 1 , or from 1 : 20 to 200:1.

6. The microbicidal composition of any of claims 1 to 4 wherein the ratio of the first biocide to the second biocide is 1 :700 to 700:1 or from 1 :500 to 50 : 1 , or from 0.05:1 to 400:1 or from 1 :250 to 75:1.

7. A method of treating an aqueous system, the method comprising adding an effective amount of a first biocide and at least one second biocide to an aqueous system, wherein the first biocide is selected from the group consisting of

monochlorourea and modified monochlorourea; and

wherein the second biocide is selected from the group consisting of methyl

monochlorourea, dimethyl monochlorourea, bromine activated monochloramine, monochloramine, hydrogen peroxide, 1-bromo-3-chloro-5,5-dimethylhydantoin, benzisothiazolone, 2-methyiisothiazolone, tetrakis (hydroxymethyl) phosphonium sulfate, methylene bisthiocyanate, 2-bromo-2-nitropropane-1 ,3,-dioi, 2,2-dibromo-3- nitrilopropionamide, N-alkyl (C12-C16)-N,N-dimethyl benzylalkonium chloride, the combination biocide 2-methyl-5-chloro-isothiazolin-3-one/2-methyl-isothazoiin-3-one, and glutaraldehyde;

with the proviso that the first biocide is different from the second biocide.

8. The method of claim 7 wherein the first biocide is monochlorourea

9. The method of claim 7 wherein the first biocide is dimethyl monochlorourea.

10. The method of claim 7 wherein at least one first biocide is selected fron the group consisting of monoch!orourea, IM-methyi-monochlorourea, N'-methyl-N-monoch!orourea, N,N-dimethyl-N'-monochlorourea, N.N'-dimethyl-N-monochlorourea, N-ethyl-N- monochlorourea, N'-ethyi-N-monoch!orourea, Ν,Ν-diethyl-N'-monochlorourea, Ν,Ν'- diethyl-N-monochlorourea.

11. The method of any of claims 7 to 10 wherein the ratio of the first biocide to the second biocide is from 1 :100 to 800: 1 or from 1 :50 to 400: 1 , or from 1 : 20

12. The method of any of claims 7 to 10 wherein the ratio of the first biocide to the second biocide is 1 :700 to 700:1 or from 1:500 to 50 :1 , or from 0.05:1 to 400:1 or from 1:250 to 75:1.

13. The method of any of claims 7 to 12 wherein the concentration of the first biocide is used in amounts of from 0.1 ppm to 100 ppm or from 0.1 to 50 ppm or from 0.1 to 25 ppm or from 0.5 to 15 ppm. in the system being treated.

14. The method of any of claims 7 to 13 wherein the concentration of the at least one second microbiocide used is less than 150 ppm or less than 100 ppm or less than 75 ppm or less than 50 ppm.

15. The method of any of claims 7 to 14 wherein at least one second biocide is selected from the group consisting of bromine activated monochloramine and

monochloramine.

16. The method of any of claims 7 to 14 wherein at least one second biocide is selected from the group consisting of 1-bromo-3-chloro-5,5-dimethylhydantoin, tetrakis (hydroxymethyl) phosphonium sulfate, 2-bromo-2-nitropropane-1 ,3,-diol, 2,2-dibromo-3- nitrilopropionamide and combination thereof.

17. The method of any of claims 7 to 14 wherein at least one second biocide is selected from the group consisting of the combination biocide 2-methyl-5-chloro-isothiazolin-3- one/2-methyl-isothazolin-3-one, and glutaraldehyde and combination thereof.

18. The method of any of claims 7 - 17 wherein the aqueous system is selected form the groups consisting of cooling water, boiler water, pulp and paper mill water, oil and gas field injection water and produced water, oil and gas pipelines and storage systems, fuel, ballast water, wastewater, pasteurizers, other industrial process water, metalworking fluids, latex, polymers, paint, coatings, adhesives, inks, personal care and household products, reverse osmosis systems, electrochemical deposition systems, fluids used in minerai extraction, mineral slurries, agricultural processing, and biorefining waters.

19. The method of any of claims 7 to 17 wherein the aqueous system is a pulp and paper mill water system.

20. The method of any of claims 7 to 17 wherein the aqueous system is a cooling water system.

21. The method of any of claims 7 to 17 wherein the aqueous system is a wastewater system.

22. The microbicidal composition of claim 2 wherein the at least one second

microbiocide is methyl monochlorourea, and a ratio of monochlorourea to methyl monochlorourea is from 1 :10 to 128:1.

23. The microbicidal composition of claim 2 wherein the at least one second

microbiocide is dimethyl monochlorourea, and a ratio of monochlorourea to dimethyl monochlorourea is from 5 0:1 to 0.6:1.

24. The microbicidal composition of claim 2 wherein the at least one second

microbiocide is bromine activated monoch!oramine, and a ratio of monochlorourea to bromine activated monochloramine is from 12.5:1 to 400:1.

25. The microbicidal composition of claim 2 wherein the at least one second

microbiocide is monochloramine, and a ratio of monochlorourea to monochloramine is from 1 :10 to 3.2:1.

26. The microbicidal composition of claim 2 wherein the at least one second

microbiocide is hydrogen peroxide, and a ratio of monochlorourea to hydrogen peroxide is from 1 :10 to 3.2:1.

27. The microbicidal composition of claim 2 wherein the at least one second

microbiocide is tetrakis (hydroxym ethyl) phosphonium sulfate, and a ratio of

monochlorourea to tetrakis (hydroxym ethyl) phosphonium sulfate is from 0.8:1 to 12.5:1.

28. The microbicidal composition of claim 2 wherein the at least one second

microbiocide is 1-bromo-3-chloro-5,5-dimethylhydantoin, and a ratio of monochlorourea to 1-bromo-3-chloro-5,5-dimethylhydantoin is from 1: 0 to 50:1.

29. The microbicidal composition of claim 2 wherein the at least one second

microbiocide is benzisothiazolone, and a ratio of monochlorourea to benzisothiazolone is from 0.4:1 to 25:1.

30. The microbicidal composition of claim 2 wherein the at least one second

microbiocide is 2-methyiisothiazo!one, and a ratio of monochlorourea to 2- methyiisothiazo!one is from 1 :100 to 25:1.

31. The microbicidal composition of claim 2 wherein the at least one second

microbiocide is methylene bisthiocyanate, and a ratio of monochlorourea to methylene bisthiocyanate is from 0.4:1 to 400:1.

32. The microbicidal composition of claim 2 wherein the at least one second

microbiocide is 2-bromo-2-nitropropane-1,3,-diol, and a ratio of monochlorourea to 2- bromo-2-nitropropane-1 ,3,-diol is from 1.6:1 to 100:1.

33. The microbicidal composition of claim 2 wherein the at least one second

microbiocide is 2,2-dibromo-3-nitrilopropionamide, and a ratio of monochlorourea to 2,2- dibromo-3-nitrilopropionamide is from 0.8:1 to 794:1.

34. The microbicidal composition of claim 2 wherein the at least one second

microbiocide is N-alkyl (C12-C1e)-N,N-dimethyl benzylalkonium chloride, and a ratio of monochlorourea to N-alkyl (Ci2-C16)-N,N-dimethyl benzylalkonium chloride is from 1 :2.5 to 200:1.

35. The microbicidal composition of claim 2 wherein the at least one second

microbiocide is the combination biocide 2-methyl-5-chIoro-isothiazolin-3-one/2-methyl- isothazolin-3-one, and a ratio of monochlorourea to the combination biocide 2-methy[-5- chloro-isothiazolin-3-one/2-methyl-isothazolin-3-one is from 1.6:1 to 3125:1.

36. The microbicidal composition of claim 2 wherein the at least one second

microbiocide is glutara!dehyde, and a ratio of monochlorourea to glutaraldehyde is from 3:1 to 100:1.

37. The microbicidal composition of claim 3 wherein the at least one second

microbiocide is monochlorourea, and a ratio of dimethyl monochlorourea to

monochlorourea is from 1 :512 to 1 :1.

38. The microbicidal composition of claim 3 wherein the at least one second

microbiocide is methyl monochlorourea, and a ratio of dimethyl monochlorourea to methyl monochlorourea is from 25:1 to 8:1.

39. The microbicidal composition of claim 3 wherein the at least one second

microbiocide is bromine activated monochlorourea, and a ratio of dimethyl

monochlorourea to bromine activated monochlorourea is from 1 :20 to 25:4.

40. The microbicidal composition of claim 3 wherein the at least one second

microbiocide is monochloramine, and a ratio of dimethyl monochlorourea to

monochloramine is from 1 :250 to 1:4.

41. The microbicidal composition of claim 3 wherein the at least one second

microbiocide is hydrogen peroxide, and a ratio of dimethyl monochlorourea to hydrogen

42. The microbicidal composition of claim 3 wherein the at least one second

microbiocide is 1-bromo-3-chloro-5,5-dimethylhydantoin, and a ratio of dimethyl monochlorourea to 1-bromo-3-chloro-5,5-dimethylhydantoin is from 1 :40 to 3:1.

43. The microbicidal composition of claim 3 wherein the at least one second

microbiocide is benzisothiazolone, and a ratio of dimethyl monochlorourea to

benzisothiazolone is from 1 :160 to 25:2.

44. The microbicidal composition of claim 3 wherein the at least one second

microbiocide is 2-methylisothiazolone, and a ratio of dimethyl monochlorourea to 2- methylisothiazolone is from 1:625 to 32:5.

45. The microbicidal composition of claim 3 wherein the at least one second

microbiocide is methylene bisthiocyanate, and a ratio of dimethyl monochlorourea to methylene bisthiocyanate is from 1 :40 to 50:1.

46. The microbicidal composition of claim 3 wherein the at least one second

microbiocide is 2-bromo-2-nitropropane-1,3J-diol, and a ratio of dimethyl monochlorourea to 2-bromo-2-nitropropane-1,3,-diol is from 2:325 to 25:2.

47. The microbicidal composition of claim 3 wherein the at least one second

microbiocide is 2J2-dibromo-3-nitrilopropionamide, and a ratio of dimethyl

monochlorourea to 2,2-dibromo-3-nitrilopropionamide is from 1 :125 to 100:1.

48. The microbicidal composition of claim 3 wherein the at least one second

microbiocide is N-alkyl (da-CieJ-N.N-dimethyl benzylalkonium chloride, and a ratio of dimethyl monochiorourea to N-alkyl {C12-Ci6)-N,N-dimethyI benzylalkonium chloride is from 1 :250 to 32:1.

49. The microbicidal composition of claim 3 wherein the at least one second microbiocide is the combination biocide 2-methyl-5-chloro-isothiazolin-3-one/2-methyl- isothazolin-3-one, and a ratio of dimethyl monochiorourea to the combination biocide 2· methyl-5-chloro-isothiazolin-3-one/2-methyl-isothazolin-3-one is from 1 :8 to 500: .

50. The microbicidal composition of claim 3 wherein the at least one second microbiocide is glutaraldehyde, and a ratio of dimethyl monochiorourea to

glutaraldehyde is from 1:500 to 32:1.

51. A method of treating an aqueous system, the method comprising adding an effective amount of at least one of the compositions of claims 1 to 50 to an aqueous system.

Description:
Synergistic Combinations of Monochlorourea and Modified Monochloroureas

FIELD OF THE INVENTION

[0001] The invention relates to synergistic combinations of biocides and methods of their use for the control of microorganisms in aqueous and water containing systems.

BACKGROUND OF THE INVENTION

[0002] Microbiai contamination of aqueous systems is a serious problem which impacts systems performance, product quality, and human health. For instance, microbiai contamination of cooling systems can cause a decrease in efficiency of the ability to cool water which leads to increased energy costs, a need for more intensive maintenance, and can develop into a harbor for pathogenic microbes such as Legionella.

Contamination of aqueous systems such as fluids used in pulp and paper-making cause paper iine breaks which result in cessations of operation, low paper quality, and contamination of paper products with microbial spores rendering them unfit for packaging food. The ubiquity of water in manufacturing, hydrocarbon extraction and processing, mining, food processing, agriculture, waste processing, and the

overwhelming majority of human endeavors ensures that control of microbiai

contamination in all these activities will always be extremely important.

[0003] The predominant strategy for the control of microbes is treatment with biocides. Biocides are used to eliminate, reduce, or otherwise contro! the number of microbes in the aqueous systems. However, the use of biocides will always add cost to operations and products and thus more effective ways to achieve microbial control are sought, !n addition, some biocides may have deficiencies in either their spectrum of antimicrobial action or operational limitations in their manner of application such as lack of

temperature stability or susceptibility to inactivation by environmental or chemical factors. Thus combinations of biocides may be used, and in particular synergistic combinations of biocides are preferred. Synergistic combinations of biocides produce a greater degree of microbial control beyond the merely additive effects of each individual biocide.

[0004] Monochlorourea, methyl monochlorourea, and dimethyl chlorourea are fast- acting biocides which are very effective in aqueous systems. [0005] Synergistic combinations of biocides can deliver an improved cost performance over those combinations which are merely additive in terms of antimicrobial efficacy.

BRIEF SUMMARY OF THE INVENTION

[0006] The invention provides synergistic biocidai compositions. These compositions are useful for controlling microorganisms in water and aqueous systems. The compositions of the invention comprise monochlorourea in combination with at least one biocide selected from the group consisting of glutaraldehyde, quaternary ammonium compounds, dibromonitropropionamide, bromonitropropanediol, methylene

bisthiocyanate, chioromethylisothiazo!one, methy!isothiazolone, benzisothiazoione, hydrogen peroxide, monochforamine, bromine-activated chlorine, methyl

monochlorourea, dimethyl monochlorourea, tetrakis hydroxymethyl phosphonium sulfate, and bromochiorodimethylhydantoin. Another composition comprises dimethyl chlorourea in combination with at least one biocide selected from the group consisting of glutaraldehyde, quaternary ammonium compounds, dibromonitropropionamide, 2- bromo-2-nitropropane-1 ,3-diol, methylene bisthiocyanate,

ch!oromethy!isothiazolone/methyiisothiazolone, methylisothiazoione, benzisothiazoione, hydrogen peroxide, monochloramine, bromine-activated chlorine, methyl

monochlorourea, and bromochiorodimethylhydantoin.

[0007] Another aspect of the invention provides a method for controlling microbes in water or an aqueous systems. The method comprises treating the system with the biocidai compositions described above by adding to the aqueous system an effective amount of the synergistic combinations of the invention.

DETAILED DESCRIPTION OF THE INVENTION

[0008] The invention provides synergistic biocidai combinations and methods of using them in the control of microorganisms. The synergistic biocidai combinations comprise monochlorourea with dimethyl monochlorourea, and monochlorourea or dimethyl monochlorourea with any one or more of the following: glutara!dehyde, quaternary ammonium compounds, 2,2-dibromo-3-nitriIopropionamide J 2-bromo-3-nitropropane-1 ,3- diol, methylene bisthiocyanate, 5-chloro-2-methylisothiazolone/2-methyiisothiazolone (3;1 ratio), 2-methylisothiazo!one, 1 ,2-benzisothiazolone, hydrogen peroxide, monochloramine, bromine-activated chlorine, methyl monochlorourea, and 1-bromo-3- chloro-5,5-dimethy!hydantoin. Additional combinations comprise dimethyl monoch!orourea with any one or more of the following: glutaraldehyde, quaternary ammonium compounds, 2,2-dibromo-3-nitrilopropionamide, 2-bromo-3-nttropropane-1 ,3- diol, methylene bisthiocyanate, 5-chloro-2-methylisothiazoione/2-methy!isothiazolone (3;1 ratio), 2-methylisothiazolone, 1 ,2-benzisothiazoione, hydrogen peroxide, monochloramine, Spectrum™ XD3899 ("bromine-activated chloramine") (Hercules Incorporated Wilmington, DE), methyl monochlorourea, and 1-bromo-3-chIoro-5,5- dimethyihydantoin. It has been discovered that these combinations are synergistic in water or aqueous systems when used for microbial control. Thus, the combined biocidal materials result in improved antimicrobial efficacy beyond that which would be expected based on the sum of their individual antimicrobial efficacies. This unexpectedly observed synergy permits reduced amounts of the biocides to be used to achieve acceptable microbial control in water and aqueous systems, potentially resulting in enhanced performance, reduced environmental impact, and reduced impact to downstream wastewater treatment systems.

[0009] The invention provides for a microbicidal composition comprising:

a first biocide and at least one second biocide

wherein the first biocide is selected from the group consisting of monochlorourea and modified monochlorourea; and

wherein the second biocide is selected from the group consisting of methyl

monochlorourea, dimethyl monochlorourea, bromine activated monochloramine, monochloramine, hydrogen peroxide, 1-bromo-3-chioro-5,5-dimethyihydantoin, benzisothiazolone, 2-methylisothiazolone, tetrakis (hydroxym ethyl) phosphonium sulfate, methylene bisthiocyanate, 2-bromo-2-nitropropane-1 ,3,-diol, 2,2-dibromo-3- nitrilopropionamide, N-alkyi (C^-C^-riN-dimethy! benzylalkonium chloride, the combination biocide 2-methyI-5-chloro-isothiazolin-3-0ne/2-methyl-isothazolin-3- one, and glutaraldehyde; with the proviso that the first biocide is different (not the same biocide)from the second biocide.

[0010] A method of treating an aqueous system, the method comprising adding an effective amount of a first biocide. and at least one second biocide to an aqueous system, wherein the first biocide is selected from the group consisting of monochlorourea and modified monochlorourea; and

wherein the second biocide is selected from the group consisting of methyl monochlorourea, dimethyl monochlorourea, bromine activated monochloramine, monochloramine, hydrogen peroxide, 1-bromo-3-chloro-5,5-dimethylhydantoin, benzisothiazolone, 2-methylisothiazolone, tetrakis (hydroxymethyl) phosphonium sulfate, methylene bisthiocyanate, 2-bromo-2-nitropropane-1 I 3,-diol, 2,2-dibromo-3- nitrilopropionamide, N-alkyl (C 12 -C 1e )-N,N-dimethyl benzy!alkonium chloride, the combination biocide 2-methy!-5-chloro-isothiazo!in-3-one/2-methyi-isothazolin-3- one, and glutaraidehyde; with the proviso that the first biocide is different (not the same biocide) from the second biocide.

[0011 ] For the purposes of this specification, the meaning of "microorganisms" and "microbes" includes, but is not limited to, bacteria, fungi, algae, protozoans, and viruses. Preferred microbes against which these compositions are effective are bacteria, it is aiso understood that the microbes within water or aqueous systems can be located suspended within the fluid (eg., planktonic) or !ocalized on a surface in contact with the aqueous system (eg., biofilms). The words and phrases "control", "microbial control", "controlling", and "antimicrobial efficacy" should be broadly construed to include within their meaning, without being limited to, inhibiting the growth of microbes, killing microbes, disinfection, preservation, sanitization, or preventing the re-growth of microbes.

[0012] As used herein ppm is measured as mass per volume or 1 ppm equals 1 mg (active) per liter

[0013] Monochlorourea and modified monochlorourea compounds may include, but are not limited to, monochlorourea, N-methy!-monochlorourea, N'-methyl-N-monochlorourea, N,N-dimethyl-N'-monochlorourea, NjN'-dimethyl-N-monochlorourea, N-ethyl-N- monochlorourea, N'-ethyl-N-monochiorourea, N,N-diethy!-N'-monochlorourea, Ν,Ν'- diethyi-N-monochlorourea.

[0014] Examples of water and aqueous systems in which the compositions are useful are cooling water, boiler water, pulp and paper mill water, oil and gas field injection water and produced water, oil and gas pipelines and storage systems, fuel, ballast water, wastewater, pasteurizers, other industrial process water, metalworking fluids, latex, polymers, paint, coatings, adhesives, inks, personal care and household products, reverse osmosis systems, electrochemical deposition systems, fluids used in mineral extraction, mineral slurries, agricultural processing, biorefining waters, and systems that use them. In addition, the compositions may be used in other areas where microbial contamination of water and aqueous systems is required. Preferred aqueous systems are cooling water, boiler water, pulp and paper processes. [0015] The monochlorourea or modified monochlorourea is used in amounts of from 0.1 ppm to 100 ppm in the system being treated or from 0.1 to 50 ppm or from 0.1 to 25 ppm or from 0.5 to 5 ppm.

[0016] Generally the concentration of the second biocide used is less than 150 ppm or less than 100 ppm or less than 75 ppm or less than 50 ppm in the system being treated. Concentrations of hydrogen peroxide used are generally greater than other biocides and can be as much as 2500 ppm or more

[0017] In some embodimentsthe ratio of monochlorourea or modified monochlorourea to second biocide can be from 1 :100 to 800:1 , or from 1 :50 to 400:1 , or from 1 : 20 to 200:1.

[0018] In some embodiments the ratio of dimethyl monochlorourea to second biocide can be from 1 :700 to 700:1 , or from 1 :500 to 50 :1 , or from 0.05:1 to 400:1 or from 1 :250 to 75:1.

[0019] A person of ordinary skill in the art using the description of the invention can readily determine the concentration of the composition required to achieve acceptable microbial control.

[0020] The components of the composition can be added to the water or aqueous system separately or blended prior to addition. A person of ordinary skill in the art can readily determine the appropriate method of addition. The composition can be added to the water or aqueous system with other additives such as, but not limited to, surfactants, scale and corrosion control compounds, ionic or non-ionic polymers, pH control agents, and other additives used for altering or modifying the chemistry of the water or aqueous system. In addition, the compositions may be used in water and aqueous systems which contain other biocidal agents.

EXAMPLES

[0021 ] The synergy indices reported in the following examples use the following formula: Synergy Index = Qa/QA + Qb/QB

where Qa is the concentration of Biocide A required to achieve complete inhibition of growth of the test microbe when used in combination with Biocide B;

QA is the concentration of Biocide A required to achieve complete inhibition of growth of the test microbe when used alone;

Qb is the concentration of Biocide B required to achieve complete inhibition of growth of the test microbe when used in combination with Biocide A; QB is the concentration of Biocide B required to achieve complete inhibition of growth of the test microbe when used alone.

[0022] In the examples the QA, QB, Qa, Qb are measured in ppm.

[0023] A synergy index (SI) of 1 indicates the interactions between the two biocides is merely additive, a SI of greater than one indicates the two biocides are antagonistic with each other, and a SI of less than 1 indicates the two biocides interact in a synergistic manner.

[0024] While there are various methods known to individuals skilled in the art for measuring levels of antimicrobial activity, in the following examples the endpoint used is known as the Minimal inhibitory Concentration, or MIC. This is the lowest concentration of a substance or substances which can achieve complete inhibition of growth.

[0025] In order to determine the Minimal inhibitory Concentration, a two-foid dilution series of the biocide is constructed with the dilutions being made in growth media. The dilutions are made in a 96 well microplate such that each well has a final volume of 280 μ! of media and biocide. The first well has, for example, a concentration of 1000 ppm biocide, the second 500 ppm, the third 250 ppm, and so forth, with the 12 th and final well in the row having no biocide at all and serving as a positive growth control. After the dilution series is constructed the wells receive an inoculum of microbe suspended in growth media such that the final concentration of microbes in the well is ~5 x 10 5 cfu/ml. In these examples the test microbe used is Escherichia coli. The cultures are incubated at an appropriate temperature for 8-24 hours, and the wells scored as positive or negative for growth based on a visual examination for turbid wells. The lowest concentration of biocide which completely inhibits growth (eg., a clear well) is designated the Minimal inhibitory Concentration.

[0026] In order to determine whether the interaction between two biocides is additive, antagonistic, or synergistic against a target microbe a modification of the MIC method known as the "checkerboard" method is employed using 96 well micropiates. To construct a checkerboard plate the first biocide is deployed using the two-fold serial dilution method used to construct an MIC plate, except that each of the eight rows is an identical dilution series which terminates after the eighth column. The second biocide is deployed by adding identical volumes of a twofold dilution series at right angles to the first series. The result is each well of the 8 x 8 well square has a different combination of biocide concentrations, yielding 64 different combinations in total. The 9 th and 10 ih columns receive no biocide at all and serve as positive and negative growth controls, respectively. After the checkerboard microplate is constructed, it is inoculated with Escherichia coli, incubated at 37°C, and scored as described for the MIC method.

Example 1 : Synergy of MCU with Methyl Monochlorourea

[0027] Minimal inhibitory concentrations were determined for both monochlorourea and methyl monochlorourea (abbreviated MMCU in Table 1) using the protocol described above with Escherichia coli as the test microbe. Using twice the concentration of the MIC expressed as parts per million as the highest concentration, checkerboard synergy piates were constructed as described, the wells inoculated to a final concentration of ~5 x 10 5 cfu/ml, incubated for 18-24 hours, and then scored visually for growth/no growth. The experiment was repeated 3 times and the results summarized below. Synergy indices were calculated according to the formula. The results indicate MCU is broadly synergistic with methyl monochlorourea from concentration ratios of MCU to methyl monochlorourea from 1 :10 to 128:1.

Example 2: Synergy of MCU with Dimethyl Monochlorourea

[0028] Minimal inhibitory concentrations were determined for both monochlorourea and methyl monochlorourea (abbreviated DMCU in Table 2) using the protocol described above with Escherichia coli as the test microbe. Using twice the concentration of the MIC expressed as parts per million as the highest concentration, checkerboard synergy plates were constructed as described, the wells inoculated to a final concentration of ~5 x 10 5 cfu/mi, incubated for 18-24 hours, and then scored visually for growth/no growth. The experiment was repeated 3 times and the results summarized below. Synergy indices were calculated according to the formula. The results indicate MCU is broadly synergistic with dimethyl monochlorourea from concentration ratios of MCU to dimethyl monochlorourea from 510:1 to 0.6:1.

Example 3: Synergy of MCU with Spectrum XD3899 (bromine activated

monochloramine)

[0029] Minimal inhibitory concentrations were determined for both monochlorourea and Spectrum™ XD3899 ( designated BAC in Table 3) using the protocol described above with Escherichia coli as the test microbe. Using twice the concentration of the MIC expressed as parts per million as the highest concentration, checkerboard synergy plates were constructed as described, the wells inoculated to a final concentration of ~5 x 10 5 cfu/ml, incubated for 18-24 hours, and then scored visually for growth/no growth. The experiment was repeated 3 times and the results summarized below. Synergy indices were calculated according to the formula. The results indicate MCU is broadly synergistic with BAC from concentration ratios of MCU to Spectrum 3899 from 12.5:1 to 400:1 .

Example 4: Synergy of MCU with Monochloramine

[0030] Minimal inhibitory concentrations were determined for both monochlorourea and monochloramine (abbreviated MCA in Table 4) using the protoco! described above with Escherichia coli as the test microbe. Using twice the concentration of the MIC expressed as parts per million as the highest concentration, checkerboard synergy plates were constructed as described, the welis inoculated to a fina! concentration of ~5 x 10 fi cfu/ml, incubated for 18-24 hours, and then scored visually for growth/no growth. The experiment was repeated 3 times and the results summarized below. Synergy indices were calculated according to the formula. The results indicate MCU is broadly synergistic with monochloramine from concentration ratios of MCU to monochloramine from 1 :10 to 128:1 .

100 47 50 6.3 8 0.63

100 47 50 3.1 16 0.57

100 47 50 1 .6 32 0.53

100 47 50 0.8 64 0.52

100 47 50 0.4 128 0.51

Example 5: Synergy of MCU with Hydrogen Peroxide

[0031 ] Minimal inhibitory concentrations were determined for both monochlorourea and hydrogen peroxide (abbreviated H202 in Table 5) using the protocol described above with Escherichia coli as the test microbe. Using twice the concentration of the MIC expressed as parts per mii!ion as the highest concentration, checkerboard synergy plates were constructed as described, the welis inoculated to a final concentration of ~5 x 10 6 cfu/ml, incubated for 18-24 hours, and then scored visually for growth/no growth. The experiment was repeated 3 times and the results summarized below. Synergy indices were calculated according to the formula. The results indicate MCU is broadly synergistic with hydrogen peroxide from concentration ratios of MCU to hydrogen peroxide from 1 :10 to 3.2:1.

Example 6: Synergy of MCU with 1 -bromo-3-chloro-5,5-dimethylhydantoin

[0032] Minimal inhibitory concentrations were determined for both monochlorourea and 1 -bromo-3-chloro-5,5-dimethylhydantoin (abbreviated BCDMH in Table 6) using the protocol described above with Escherichia coli as the test microbe. Using twice the concentration of the MIC expressed as parts per million as the highest concentration, checkerboard synergy plates were constructed as described, the wells inoculated to a final concentration of ~5 x 10 s cfu/ml, incubated for 18-24 hours, and then scored visually for growth/no growth. The experiment was repeated 3 times and the results summarized below. Synergy indices were calculated according to the formula. The results indicate MCU is broadiy synergistic with 1 -bromo-3-ch!oro-5,5-dimethylhydantoin from

concentration ratios of MCU to 1-bromo-3-chloro-5,5-dimethyihydantoin from 1 :10 to 50:1.

Example 7: Synergy of MCU with Benzisothiazolone

[0033] Minima! inhibitory concentrations were determined for both monoch!orourea and benzisothiazolone (abbreviated BIT in Table 7) using the protocol described above with Escherichia coli as the test microbe. Using twice the concentration of the M!C expressed as parts per million as the highest concentration, checkerboard synergy plates were constructed as described, the wells inoculated to a final concentration of ~5 x 10 s cfu/ml, incubated for 18-24 hours, and then scored visually for growth/no growth. The experiment was repeated 3 times and the results summarized below. Synergy indices were calculated according to the formu!a3. The results indicate MCU is broadly synergistic with benzisothiazolone from concentration ratios of MCU to

benzisothiazolone from 0.4:1 to 100:1.

Example 8: Synergy of MCU with 2-Methyl Isothiazolone

[0034] Minimal inhibitory concentrations were determined for both monochlorourea and 2-methyl isothiazolone (abbreviated MIT in Table 8) using the protocol described above with Escherichia coli as the test microbe. Using twice the concentration of the MIC expressed as parts per million as the highest concentration, checkerboard synergy plates were constructed as described, the welis inoculated to a final concentration of -5 x 10 5 cfu/ml, incubated for 18-24 hours, and then scored visually for growth/no growth. The experiment was repeated 3 times and the results summarized below. Synergy indices were calculated according to the formula . The results indicate MCU is broadly synergistic with 2-methyl isothiazolone from concentration ratios of MCU to 2-methyl isothiazolone from 1 :100 to 26:1.

100 180 50 8 6.4 0.54

100 180 50 4 12.5 0.52

100 180 50 2 25 0.51

Example 9: Synergy of MCU with methylene bisthiocyanate

[0035] Minimal inhibitory concentrations were determined for both monochlorourea and methylene bisthiocyanate (abbreviated MBT in Table 9) using the protocol described above with Escherichia coli as the test microbe. Using twice the concentration of the MIC expressed as parts per million as the highest concentration, checkerboard synergy plates were constructed as described, the wells inoculated to a final concentration of ~5 x 10 5 cfu/ml, incubated for 18-24 hours, and then scored visually for growth/no growth. The experiment was repeated 3 times and the results summarized below. Synergy indices were calculated according to the formula. The results indicate MCU is broadly synergistic with methylene bisthiocyanate from concentration ratios of MCU to methylene bisthiocyanate from 0.4:1 to 400:1.

Example 10: Synergy of MCU with 2-bromo-2-nitropropane-1 ,3,-diol

[0036] Minimal inhibitory concentrations were determined for both monochlorourea and 2-bromo-2-nitropropane-1 ,3,-diol (abbreviated BNPD in Table 10) using the protocol described above with Escherichia coli as the test microbe. Using twice the concentration of the MIC expressed as parts per million as the highest concentration, checkerboard synergy p!ates were constructed as described, the wells inoculated to a final concentration of ~5 x 10 5 cfu/ml, incubated for 18-24 hours, and then scored visually for growth/no growth. The experiment was repeated 3 times and the results summarized below. Synergy indices were calculated according to the formula. The results indicate MCU is broadly synergistic with 2-bromo-2-nitropropane-1 ,3,-dioi from concentration ratios of MCU to 2-bromo-2-nitropropane-1 ,3,-diol from 1.6:1 to 00:1.

Example 1 1 : Synergy of MCU with 2,2-dibromo-3-nitrilopropionamide

[0037] Minimal inhibitory concentrations were determined for both monochlorourea and 2,2-dibromo-3-nitrilopropionamide (abbreviated DBNPA in Table 1 1 using the protocol described above with Escherichia coli as the test microbe. Using twice the concentration of the MIC expressed as parts per million as the highest concentration, checkerboard synergy plates were constructed as described, the wells inoculated to a final

concentration of ~5 x 10 5 cfu/ml, incubated for 18-24 hours, and then scored visually for growth/no growth. The experiment was repeated 5 times and the results summarized below. Synergy indices were calculated according to the formula . The results indicate MCU is broadly synergistic with 2,2-dibromo-3-nitrilopropionamide from concentration ratios of MCU to 2,2-dibromo-3-nitri!opropionamide from 0.8:1 to 794:1.

100 11 25 4 6.3 0.61

100 11 25 2 12.5 0.43

100 11 50 1 50.0 0.59

100 11 50 0.5 100 0.55

100 11 50 0.25 200 0.52

100 11 50 0.125 400 0.51

100 11 50 0.063 794 0.51

Example 12: Synergy of MCU with N-alkyi (C 12 -C 16 )-N,N-dimethyl benzyia!konium chloride

[0038] Minimal inhibitory concentrations were determined for both monochlorourea and N-aikyl (C 12 -C 16 )-N,N-dtmethyl benzylalkonium chloride (abbreviated QAC in Table 12) using the protocol described above with Escherichia coti as the test microbe. Using twice the concentration of the MIC expressed as parts per million as the highest concentration, checkerboard synergy plates were constructed as described, the wells inoculated to a final concentration of ~5 x 10 5 cfu/ml, incubated for 18-24 hours, and then scored visually for growth/no growth. The experiment was repeated 5 times and the results summarized below. Synergy indices were calculated according to the formula . The results indicate MCU is broadly synergistic with N-alkyl (C 12 -C 16 )-N,N-dimethyl benzylalkonium chloride from concentration ratios of MCU to N-alkyl {C 12 -C 16 )-N,N- dimethyl benzylalkonium chloride from 1 :2.5 to 200:1 .

Example 13: Synergy of MCU with the combination biocide 2-methyi-5-chIoro- isothiazo!in-3-one/2-methyl-!sothazoiin-3-one

[0039] Minima! inhibitory concentrations were determined for both monochlorourea and the CMIT/MIT combination biocide using the protocol described above with Escherichia co// as the test microbe. Using twice the concentration of the MIC expressed as parts per million as the highest concentration, checkerboard synergy plates were constructed as described, the wells inoculated to a final concentration of ~5 x 10 5 cfu/mi, incubated for 18-24 hours, and then scored visually for growth/no growth. The experiment was repeated 5 times and the results summarized below. Synergy indices were calculated according to the formula. The results indicate MCU is broadly synergistic with the CMIT/MiT combination biocide from concentration ratios of MCU to the CMIT/MIT combination biocide from 1.6:1 to 3125:1.

Example 14: Synergy of MCU with Glutaraldehyde

[0040] Minimal inhibitory concentrations were determined for both monoch!orourea and g!utaraldehyde (abbreviated GLUT in Table 14 below) using the protocol described above with Escherichia coli as the test microbe. Using twice the concentration of the MIC expressed as parts per million, as the highest concentration, checkerboard synergy plates were constructed as described, the wells inoculated to a final concentration of ~5 x 10 5 cfu/ml, incubated for 18-24 hours, and then scored visually for growth/no growth. The experiment was repeated 5 times and the results summarized below. Synergy indices were calculated according to the formula. The results indicate MCU is broadly synergistic with glutaraldehyde from concentration ratios of MCU to giutaraldehyde from 3.1 : 1 to 100: 1.

Example 15: Synergy of DMCU with Monochlorourea

[0041] Minimal inhibitory concentrations were determined for both dimethyl chiorourea and monochlorourea (abbreviated MCU in Table 15) using the protocol described above with Escherichia coli as the test microbe. Using twice the concentration of the MIC expressed as parts per million as the highest concentration, checkerboard synergy plates were constructed as described, the wells inoculated to a final concentration of ~5 x 10 s cfu/ml, incubated for 18-24 hours, and then scored visually for growth/no growth. The experiment was repeated 3 times and the results summarized below. Synergy indices were calculated according to the formula. The results indicate DMCU is broadly synergistic with monochlorourea from concentration ratios of DMCU to monochlorourea from 1 :512 to 1 :1 .

10 100 3.13 50.00 1/16 0.81

10 100 3.13 25.00 1/8 0.56

10 100 6.25 25.00 1/4 0.88

10 100 6.25 12.50 1/2 0.75

10 100 6.25 6.25 1 0.69

10 100 10.00 6.25 3/2 1.06

Example 16: Synergy of DMCU with Methyl Monoch!orourea

[0042] Minimal inhibitory concentrations were determined for both dimethyl chlorourea and methyl monochlorourea (abbreviated MMCU in Table 16) using the protocol described above with Escherichia coli as the test microbe. Using twice the concentration of the MIC expressed as parts per million as the highest concentration, checkerboard synergy plates were constructed as described, the wells inoculated to a final

concentration of ~5 x 10 s cfu/ml, incubated for 18-24 hours, and then scored visually for growth/no growth. The experiment was repeated 3 times and the results summarized below. Synergy indices were calculated according to the formula. The results indicate DMCU is broadly synergistic with methyl monochlorourea from concentration ratios of DMCU to methyl monochlorourea from 1 : 125 to 8: 1 .

Example 17: Synergy of DMCU with Spectrum XD3899

[0043] Minimal inhibitory concentrations were determined for both dimethyl chlorourea and Spectrum™ XD3899 ("bromine-activated chlorine", abbreviated BAC in Table 17) using the protocol described above with Escherichia coli as the test microbe. Using twice the concentration of the MIC expressed as parts per million as the highest concentration, checkerboard synergy piates were constructed as described, the weils inoculated to a final concentration of ~5 x 10 s cfu/ml, incubated for 18-24 hours, and then scored visually for growth/no growth. The experiment was repeated 3 times and the results summarized below. Synergy indices were calculated according to the formula. The results indicate DMCU is broadly synergistic with BAC from concentration ratios of DMCU to BAC from 1 :20 to 25:4.

Example 18: Synergy of DMCU with Monochloramine

[0044] Minimal inhibitory concentrations were determined for both dimethyl chlorourea and monochloramine (abbreviated MCA in Table 18) using the protocol described above with Escherichia colias the test microbe. Using twice the concentration of the MIC expressed as parts per million as the highest concentration, checkerboard synergy plates were constructed as described, the weils inoculated to a final concentration of ~5 x 10 5 cfu/ml, incubated for 18-24 hours, and then scored visually for growth/no growth. The experiment was repeated 3 times and the results summarized below. Synergy indices were calculated according to the formula. The results indicate DMCU is broadly synergistic with monochloramine from concentration ratios of DMCU to monochioramine from 1 :250 to 1 :4.

Example 19: Synergy of DMCU with Hydrogen Peroxide

[0045] Minimal inhibitory concentrations were determined for both dimethyl chiorourea and hydrogen peroxide (abbreviated H202 in Table 19) using the protocol described above with Escherichia coli as the test microbe. Using twice the concentration of the MIC expressed as parts per million as the highest concentration, checkerboard synergy plates were constructed as described, the wells inoculated to a final concentration of ~5 x 10 5 cfu/ml, incubated for 18-24 hours, and then scored visually for growth/no growth. The experiment was repeated 3 times and the results summarized below. Synergy indices were calculated according to the formula. The results indicate DMCU is broadly synergistic with hydrogen peroxide from concentration ratios of DMCU to hydrogen peroxide from 1 :640 to 2:5.

10 1000 1.56 8 1/5 0.16

10 , 1000 6.25 16 2/5 0.64

Exampie 20: Synergy of DMCU with 1 -bromo-3-ch!oro-5,5-dimethy[hydantoin

[0046] Minimal inhibitory concentrations were determined for both dimethyl chlorourea and 1 -bromo-3-chloro-5,5-dimethylhydantoin (abbreviated BCDMH in Table 20) using the protocol described above with Escherichia coli as the test microbe. Using twice the concentration of the MIC expressed as parts per million as the highest concentration, checkerboard synergy plates were constructed as described, the wells inoculated to a final concentration of ~5 x 10 5 cfu/ml, incubated for 18-24 hours, and then scored visually for growth/no growth. The experiment was repeated 3 times and the results summarized below. Synergy indices were calculated according to the formula. The results indicate DMCU is broadly synergistic with 1 -bromo-3-chloro-5,5-dimethyihydantoin from concentration ratios of DMCU to 1 -bromo-3-chloro-5,5-dimethyihydantoin from 1 :40 to 3:1.

Example 21 : Synergy of DMCU with Benzisothiazolone

[0047] Minimal inhibitory concentrations were determined for both dimethyl chlorourea and benzisothiazolone (abbreviated BIT in Table 21 ) using the protocol described above with Escherichia co!i as the test microbe. Using twice the concentration of the MIC expressed as parts per million as the highest concentration, checkerboard synergy plates were constructed as described, the wells inoculated to a final concentration of ~5 x 10 5 cfu/ml, incubated for 18-24 hours, and then scored visually for growth/no growth. The experiment was repeated 3 times and the results summarized below. Synergy indices were caiculated according to the formula. The results indicate DMCU is broadiy synergistic with benzisothiazoione from concentration ratios of DMCU to

benzisothiazolone from 1 :160 to 25:2.

Example 22: Synergy of DMCU with 2-Methyl !sothiazoione

[0048] Minimal inhibitory concentrations were determined for both dimethyl chlorourea and 2-methyl isothiazoione (abbreviated MIT in Table 22) using the protocol described above with Escherichia coli as the test microbe. Using twice the concentration of the MIC expressed as parts per million as the highest concentration, checkerboard synergy plates were constructed as described, the wells inoculated to a final concentration of ~5 x 10 5 cfu/ml, incubated for 18-24 hours, and then scored visually for growth/no growth. The experiment was repeated 3 times and the results summarized beiow. Synergy indices were calculated according to the formula. The results indicate DMCU is broadly synergistic with 2-methyl isothiazolone from concentration ratios of DMCU to 2-methyl isothiazolone from 1 :625 to 32:5.

Example 23: Synergy of DMCU with methylene bisthiocyanate

[0049] Minima! inhibitory concentrations were determined for both dimethyl chlorourea and methylene bisthiocyanate (abbreviated MBT in Table 23) using the protocol described above with Escherichia coli as the test microbe. Using twice the concentration of the MIC expressed as parts per million as the highest concentration, checkerboard synergy plates were constructed as described, the weils inoculated to a final

concentration of ~5 x 10 5 cfu/ml, incubated for 18-24 hours, and then scored visually for growth/no growth. The experiment was repeated 3 times and the results summarized below. Synergy indices were calculated according to the formula. The results indicate DMCU is broadly synergistic with methylene bisthiocyanate from concentration ratios of DMCU to methylene bisthiocyanate from 1 :40 to 50:1.

10 8 0.20 4 1/20 0.52

10 8 0.10 2 1/20 0.26

10 8 0.78 4 1/5 0.58

10 8 6.25 2 3 0.88

10 8 6.25 1 6 0.75

10 8 6.25 0.5 25/2 0.69

10 8 6.25 0.25 25 0.66

10 8 6.25 0.125 50 0.64

10 8 10.00 0.125 80 1.27

Example 24: Synergy of DMCU with 2-bromo-2-nitropropane-1 J 3,-diol

[0050] Minimal inhibitory concentrations were determined for both dimethyl ch!orourea and 2-bromo-2-nitropropane-1 ,3,-diol (abbreviated BNPD in Table 24) using the protocol described above with Escherichia coii as the test microbe. Using twice the concentration of the MIC expressed as parts per million as the highest concentration, checkerboard synergy plates were constructed as described, the wells inoculated to a final

concentration of ~5 x 10 5 cfu/ml, incubated for 18-24 hours, and then scored visually for growth/no growth. The experiment was repeated 3 times and the results summarized below. Synergy indices were calculated according to the formula. The results indicate DMCU is broadly synergistic with 2-bromo-2-nitropropane-1 ,3,-dio! from concentration ratios of DMCU to 2-bromo-2-nitropropane-1 ,3,-diol from 2:325 to 25:2.

Example 25: Synergy of DMCU with 2,2-dibromo-3-nitrilopropionamide

[0051 ] Minimal inhibitory concentrations were determined for both dimethyl chlorourea and 2,2-dibromo-3-nitri!opropionamide (abbreviated DBNPA in Table 25) using the protocol described above with Escherichia COII SLQ the test microbe. Using twice the concentration of the MIC expressed as parts per million as the highest concentration, checkerboard synergy plates were constructed as described, the wells inoculated to a final concentration of ~5 x 10 5 cfu/mi, incubated for 18-24 hours, and then scored visually for growth/no growth. The experiment was repeated 5 times and the results summarized below. Synergy indices were calculated according to the formula. The results indicate DMCU is broadly synergistic with 2,2-dibromo-3-nitrilopropionamide from concentration ratios of DMCU to 2,2-dibromo-3-nitri!opropionamide from 1 :125 to 100:1.

Example 26: Synergy of DMCU with N-aikyl (C l2 -C 16 )-N,N-dimethyi benzylalkonium chloride

[0052] Minimal inhibitory concentrations were determined for both dimethyl chlorourea and N-aikyl (C 12 -C 16 )-N,N-dimethyi benzyiaikonium chloride (abbreviated QAC in Table 26) using the protocoi described above with Escherichia cotias the test microbe. Using twice the concentration of the MIC expressed as parts per million as the highest concentration, checkerboard synergy plates were constructed as described, the wells inoculated to a final concentration of ~5 x 10 5 cfu/ml, incubated for 18-24 hours, and then scored visually for growth/no growth. The experiment was repeated 5 times and the results summarized below. Synergy indices were calculated according to the formula. The results indicate DMCU is broadly synergistic with N-a!kyi (C^-C^-N.N-dimethyl benzylalkonium chloride from concentration ratios of DMCU to N-alky! (C 12 -C 16 )-N,N- dimethyl benzylalkonium chloride from 1 :250 to 32: 1.

10 27 8.00 0.5 16 0.64

10 27 6.25 0.25 25 0.63

10 27 8.00 0.25 32 0.81

Example 27: Synergy of DMCU with the combination biocide 2-methyl-5-ch!oro- isothiazolin-3-one/2-methyi-isothazolin-3-one

[0053] Minimal inhibitory concentrations were determined for both dimethyl chlorourea and the 2-methyl-5-chloro-isothiazo!in-3-one/2-methyl-isothazolin-3- one combination biocide (abbreviated CMIT/M!T in Table 27) using the protocol described above with Escherichia coli as the test microbe. Using twice the concentration of the MIC expressed as parts per miliion as the highest concentration, checkerboard synergy plates were constructed as described, the wells inoculated to a finai concentration of ~5 x 0 5 cfu/ml, incubated for 18-24 hours, and then scored visually for growth/no growth. The experiment was repeated 5 times and the results summarized below. Synergy indices were calculated according to the formula. The results indicate DMCU is broadly synergistic with the CMIT/MIT combination biocide from concentration ratios of DMCU to the CMIT/MIT combination biocide from 1 :8 to 500:1.

10 2 8 0.016 500 0.81

10 2 12.5 0.016 800 1.26

Example 28: Synergy of DMCU with Glutaraldehyde

[0054] Minima! inhibitory concentrations were determined for both dimethyl ch!orourea and glutaraldehyde (abbreviated GLUT in the Table below) using the protocol described above with Escherichia coli as the test microbe. Using twice the concentration of the MIC expressed as parts per million, as the highest concentration, checkerboard synergy plates were constructed as described, the wells inoculated to a final concentration of ~5 x 10 5 cfu/ml, incubated for 18-24 hours, and then scored visually for growth/no growth. The experiment was repeated 5 times and the results summarized below. Synergy indices were calculated according to the formula. The results indicate DMCU is broadly synergistic with glutaraldehyde from concentration ratios of DMCU to glutaraldehyde from 1 :500 to 32:1.

Table 28

Used alone Used in Combination

DMCU GLUT DMCU GLUT

DMCU/GLUT

MIC MIC MIC MIC

Ratio

(QA) (QB) (Qa) (Qb) Synergy

Index

10 45 0.063 32 1/500 0.72

10 45 0.098 32 1/325 0.72

10 45 0.098 16 2/325 0.37

10 45 0.125 16 1/125 0.55

10 45 4 16 1/4 0.76

10 45 6.25 16 2/5 0.98

10 45 4 8 1/2 0.58

10 45 6.25 8 4/5 0.80

10 45 4 4 1/1 0.49

10 45 8 4 2/1 0.67

10 45 12.5 4 3.125/1 0.89

10 45 8 2 4/1 0.63

10 45 12.5 2 6.25/1 0.86

10 45 8 1 8/1 0.82

10 45 6.25 0.5 12.5/1 0.64

10 45 8 0.5 16/1 0.61

10 45 6.25 0.25 25/1 0.63

10 45 8 0.25 32/1 0.81

10 45 12.5 0.25 50/1 1.26